All companies
Sartorius AG logo

What smart money is saying about Sartorius AGGermany flag

SRT.DE · Healthcare · Medical Instruments & Supplies · Market cap $16.56B

1 fund in our archive has pitched Sartorius AG — most recently AVI Global Trust in September 2026.

Company profile

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Get an email when a fund buys, sells or pitches it

Summarize with Warren AI
1
Reported positions
0
Bought
0
Sold
2
Letters

Position history

Every position in Sartorius AG on record in the archive was reported in Q3 2026, across 1 fund letter, with no move described.

Fund letters reporting a position in Sartorius AG, by quarter
QuarterLettersBoughtSoldTheses
Q3 20261001

Fund activity · 1 position

Fund coverage · 1 thesis

Read every full thesis on Sartorius AG

Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans→
Share this ledger